Zhejiang Teruisi Biopharmaceutical, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zhejiang Teruisi Biopharmaceutical, Inc.
The China-based biopharma company is seeking up to $602.8m gross in its Hong Kong IPO.
Managing Partner at Ascent Biomedical Ventures Geoffrey Smith recently began a new role at Mount Sinai Medical School that is helping academics translate their knowledge into real-world commercial opportunities.
Brief profiles of these recently formed companies: Acetylon Pharmaceuticals, Nanovis, TargAnox, Treventis
In Vivo briefly describes these recently founded companies: Acetylon Pharmaceuticals, Avineuro Pharmaceuticals, Nanovis, TargAnox, TheraCell and Treventis.
- Other Names / Subsidiaries
- Zhejiang Teruisi Pharmaceutical Inc.
- Zhejiang Tellus Pharmaceutical Co., Ltd.